[Somatomedins (author's transl)].
Research on somatomedins (insulin-like growth factors) has progressed greatly over the past few years. In the present review we summarize, in addition to our own results, some recent findings concerning the structure of these factors, their carrier protein, their biosynthesis and hormonal regulation. We also stress the interest of specific assays for their use in clinical investigation.
D000172:Acromegaly / Q000097:blood; D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism; D002648:Child; D013006:Growth Hormone / Q000502:physiology; D006133:Growth Substances / Q000502:physiology*; D006801:Humans; D007328:Insulin / Q000502:physiology*; D018969:Insulin-Like Growth Factor Binding Proteins; D007335:Insulin-Like Growth Factor II; D008099:Liver / Q000378:metabolism; D010455:Peptides / Q000502:physiology*; D051381:Rats; D013002:Somatomedins / Q000096:biosynthesis / Q000172:deficiency / Q000378:metabolism / Q000502:physiology*
D002352:Carrier Proteins; D013006:Growth Hormone; D006133:Growth Substances; D007328:Insulin; D018969:Insulin-Like Growth Factor Binding Proteins; D007335:Insulin-Like Growth Factor II; D010455:Peptides; D013002:Somatomedins
Somatomédines.